<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-13T20:27:35+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2706】领袖汇聚倒计时丨本周五，中国肿瘤医药营销趋势论坛隆重启幕</title>
    <updated>2021-01-13T19:12:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/8XffuPkTAJdZlLmcAFce2g</id>
    <link href="https://mp.weixin.qq.com/s/8XffuPkTAJdZlLmcAFce2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「2020金研奖」妇科肿瘤单元入围名单揭晓</title>
    <updated>2021-01-13T19:12:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/xZoD5zfG7HyIRPjCIWlrXA</id>
    <link href="https://mp.weixin.qq.com/s/xZoD5zfG7HyIRPjCIWlrXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021 ASCO-GI即将开幕，胃食管癌领域重磅研究抢先看</title>
    <updated>2021-01-13T19:12:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/1LvurmU21cyOjVMvbLj1hQ</id>
    <link href="https://mp.weixin.qq.com/s/1LvurmU21cyOjVMvbLj1hQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>探索不断——靶向CDK4/6抑制剂三大辅助治疗研究结果相左，入组人群、治疗时长和药物差异等为未来辅助治疗研究开展带来了何种启示</title>
    <updated>2021-01-13T19:12:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/5qD-Sefx3iOA_HN4y4x5FA</id>
    <link href="https://mp.weixin.qq.com/s/5qD-Sefx3iOA_HN4y4x5FA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>郭军教授：多项肾癌研究数据出炉，结果令人鼓舞，期待青年才俊利用本土优势开展更多创新性研究</title>
    <updated>2021-01-13T19:12:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/DwZSs3qkMt54iZAQkGz_pA</id>
    <link href="https://mp.weixin.qq.com/s/DwZSs3qkMt54iZAQkGz_pA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021全新出发：《龙哥查房》每周三为您呈现 MDT精彩学术盛宴！</title>
    <updated>2021-01-13T19:12:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/vDjw9pEXw1_1fmz3T_13zA</id>
    <link href="https://mp.weixin.qq.com/s/vDjw9pEXw1_1fmz3T_13zA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>邬麟教授团队发表最新研究成果，达可替尼一线治疗EGFR突变NSCLC脑转移患者的ORR高达92.9%！</title>
    <updated>2021-01-13T19:12:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/59mWI8G5cMhQU9eg9Jdcyg</id>
    <link href="https://mp.weixin.qq.com/s/59mWI8G5cMhQU9eg9Jdcyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>研究者说 | 瑞派替尼治疗一例小肠GIST患者引发的思考</title>
    <updated>2021-01-13T19:12:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/BlFo4vTR3UDKvNukPSoeXQ</id>
    <link href="https://mp.weixin.qq.com/s/BlFo4vTR3UDKvNukPSoeXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2705】《肺癌多学科团队诊疗中国专家共识》重磅发布！吴一龙教授深度解读共识亮点</title>
    <updated>2021-01-12T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/TgWRZe28KWBStzWrGtwnfA</id>
    <link href="https://mp.weixin.qq.com/s/TgWRZe28KWBStzWrGtwnfA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年度巨制丨「骨与软组织肿瘤药物盘点」SESSION 2：骨肉瘤前沿临床研究</title>
    <updated>2021-01-12T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/lCYVxQ1mqQzb0VqLoE_SRg</id>
    <link href="https://mp.weixin.qq.com/s/lCYVxQ1mqQzb0VqLoE_SRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>领袖汇聚倒计时丨中国肿瘤医药营销趋势论坛—市场及销售分论坛</title>
    <updated>2021-01-12T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/WwxYOLGrAhnUEOp-X9ThCQ</id>
    <link href="https://mp.weixin.qq.com/s/WwxYOLGrAhnUEOp-X9ThCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>精准强效，多维获益：百济神州骨健康论坛暨安加维®SRE上市会盛大召开</title>
    <updated>2021-01-12T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/MXi5LIbSHAaxNyzRGbAddw</id>
    <link href="https://mp.weixin.qq.com/s/MXi5LIbSHAaxNyzRGbAddw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【专家采访】张兰军教授：免疫治疗为提高肺癌5年生存率做出贡献，帕博利珠单抗慈善赠药计划助力提高药物可及性</title>
    <updated>2021-01-12T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/5HYRSqosFwpOk0jr9QGtag</id>
    <link href="https://mp.weixin.qq.com/s/5HYRSqosFwpOk0jr9QGtag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张苏展教授：等效优质，经济可及，安可达为中国晚期结直肠癌患者带来福音</title>
    <updated>2021-01-12T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/d2m1kfsoLOh9l9ktooJalA</id>
    <link href="https://mp.weixin.qq.com/s/d2m1kfsoLOh9l9ktooJalA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【乳此可奈】邸立军教授：奈拉替尼在HER2阳性晚期乳腺癌患者中的应用</title>
    <updated>2021-01-12T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/PNzgpR5jHLKwcpICQMTVpw</id>
    <link href="https://mp.weixin.qq.com/s/PNzgpR5jHLKwcpICQMTVpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张敬杰教授&amp;叶峰教授：抗HER2治疗更新迭代，HPK守护治愈之光</title>
    <updated>2021-01-12T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/Z5l_tFwYuOk3IDKt-5gL_A</id>
    <link href="https://mp.weixin.qq.com/s/Z5l_tFwYuOk3IDKt-5gL_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2704】【JCO】MSI/dMMR Ⅲ期结肠癌可从含奥沙利铂的辅助化疗中获益</title>
    <updated>2021-01-11T19:46:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/V-b-jtFDt9BlLiKLjsl3UA</id>
    <link href="https://mp.weixin.qq.com/s/V-b-jtFDt9BlLiKLjsl3UA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【JAMA】辅助卡培他滨在三阴性乳腺癌中的应用</title>
    <updated>2021-01-11T19:46:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/Sh1ByvsGAM7JJlKLpxaMcA</id>
    <link href="https://mp.weixin.qq.com/s/Sh1ByvsGAM7JJlKLpxaMcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>领袖汇聚倒计时丨中国肿瘤医药营销趋势论坛—准入及支付分论坛</title>
    <updated>2021-01-11T19:46:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/UlL3uKfUVkR-ppXJ0uFTSg</id>
    <link href="https://mp.weixin.qq.com/s/UlL3uKfUVkR-ppXJ0uFTSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【专家采访】陆舜教授：帕博利珠单抗KEYNOTE-024研究5年生存率振奋人心，亲民的慈善赠药计划为广大患者保驾护航</title>
    <updated>2021-01-11T19:46:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/OuShbns5BQUpD13hXG199g</id>
    <link href="https://mp.weixin.qq.com/s/OuShbns5BQUpD13hXG199g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>